Agilent Technologies (NYSE:A) Stock Rating Lowered by Wall Street Zen

Agilent Technologies (NYSE:A) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday, Wall Street Zen reports.

A number of other equities research analysts have also commented on the stock. Citigroup upped their price target on shares of Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Barclays raised their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Thursday, August 27th. Stifel Nicolaus boosted their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Thursday, August 27th. Jefferies Financial Group began coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective for the company. Finally, Piper Sandler started coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $170.33.

Agilent Technologies Price Performance

A opened at $167.83 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The stock’s 50 day simple moving average is $152.80 and its 200 day simple moving average is $133.56. The firm has a market cap of $47.32 billion, a price-to-earnings ratio of 33.04, a PEG ratio of 2.55 and a beta of 1.21. Agilent Technologies has a 1 year low of $108.35 and a 1 year high of $177.05.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The business’s revenue was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, analysts predict that Agilent Technologies will post 6.2 earnings per share for the current year.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director directly owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. The trade was a 11.41% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Institutional Investors Weigh In On Agilent Technologies

Institutional investors and hedge funds have recently modified their holdings of the stock. Bank of Nova Scotia bought a new position in Agilent Technologies in the second quarter worth about $58,539,000. Dudley & Shanley Inc. boosted its position in Agilent Technologies by 25.9% during the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after acquiring an additional 14,300 shares in the last quarter. BIP Wealth LLC purchased a new position in shares of Agilent Technologies during the 2nd quarter worth approximately $834,000. Capricorn Fund Managers Ltd bought a new position in shares of Agilent Technologies in the 1st quarter worth approximately $8,161,000. Finally, Sivia Capital Partners LLC bought a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $1,818,000.

About Agilent Technologies

Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.

The company’s products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.